Skip to content
PubMed This is a summary of 6 peer-reviewed journal articles Updated
Dermatology

Can Lichen Planopilaris Relapse After Stopping Treatment?

At a Glance

Lichen planopilaris can become active again after medication is tapered or stopped, and ongoing inflammation may cause permanent hair loss. A dermatologist should guide any dose change and continue monitoring for new hair loss, burning, tenderness, redness, or scale.

Yes, lichen planopilaris (LPP) can become active again after your symptoms have settled down and you reduce or stop your medication. Because LPP causes permanent hair loss if left unchecked, doctors often prefer a cautious approach when adjusting treatments that are currently keeping your condition under control.

The main goal of treatment is to control active inflammation and preserve your remaining hair follicles; treatments cannot regrow hair in areas where scarring has already occurred [1].

Understanding the Risk of Relapse

It is difficult to predict exactly who will experience a flare-up or when it might happen. In one retrospective study looking at patients with LPP and a related condition called frontal fibrosing alopecia, about 29% of patients experienced a clinical flare-up after stopping their treatment [2]. Another retrospective study looking at patients whose LPP had stabilized or slowed found that, on average, a recurrence of symptoms or hair loss happened about 1.8 years later [3].

Achieving “complete remission”—which means no detectable active inflammation or new hair loss—is possible but takes time. One study of LPP patients found that for those who reached complete remission, it took an average of 46 months of treatment [4].

It is important to remember that these numbers are averages from specific studies and do not predict your individual timeline. Because the timeline varies so much, ongoing monitoring is essential even when you feel your disease is quiet.

Adjusting Medication

Depending on the specific medication, your dose, and how long you have been taking it, your dermatologist may gradually reduce your dose over time (called a taper) or stop it entirely [5][2].

There is no single rule for all LPP treatments. For instance, gradual reduction is sometimes used for safety (such as with oral corticosteroids), or as a way for your doctor to carefully observe if the inflammation stays controlled at lower doses [5][2].

Do not stop or change your systemic medication without asking your prescribing clinician. Abruptly stopping without medical supervision can put your remaining hair at risk or cause drug-specific safety issues.

Maintenance Treatment and Ongoing Monitoring

Because ongoing active inflammation can lead to additional permanent hair loss, your doctor may recommend a maintenance strategy. This is individualized to your specific situation and may involve staying on a low dose of a systemic medication, or using a topical treatment (applied directly to the scalp) [1].

Even if you stop medication completely, your care team will want to continue monitoring your scalp. You cannot always feel when LPP is active; inflammation can occur without symptoms, and conversely, itching or redness can have causes other than LPP. Therefore, self-monitoring does not replace regular dermatologic examinations. Your doctor will look for signs of returning inflammation using a combination of methods:

  • Symptom checks: Asking about returning itchiness, burning, or tenderness [6][5].
  • Trichoscopy: Using a special magnifying tool to look closely at your scalp for redness or scale around the hair follicles [6][5].
  • Photographs: Taking standard pictures to track any subtle spread of hair loss over time [6][5].

When to Contact Your Dermatologist

If you notice new or spreading patches of hair loss, increased shedding, persistent burning or tenderness, or new scale around your hair follicles, contact your dermatologist promptly. They can review your symptoms and determine whether your treatment plan needs to be restarted, increased, or changed [5][1].

Common questions in this guide

Can lichen planopilaris come back after treatment is stopped?
Yes. Lichen planopilaris can become active again after symptoms settle and medication is reduced or stopped; one study found clinical flare-ups in about 29% of patients after treatment cessation. Individual risk and timing vary, so ongoing scalp monitoring remains important.
How long after stopping treatment might lichen planopilaris relapse?
The timing varies widely from person to person. In one study of patients whose lichen planopilaris had stabilized or slowed, recurrence of symptoms or hair loss occurred on average about 1.8 years later, but this average does not predict an individual timeline.
Do I need to taper my lichen planopilaris medication?
Some medications may need to be gradually reduced, while others may be stopped only under clinician guidance. The schedule depends on the specific drug, dose, and length of treatment, so do not stop or change systemic medication on your own.
What signs could mean my lichen planopilaris is flaring again?
New or spreading hair loss, increased shedding, persistent burning or tenderness, itching, or new redness or scale around hair follicles can signal returning activity. Symptoms alone cannot confirm a flare because inflammation may occur without symptoms and scalp discomfort can have other causes, so a dermatologist should assess concerning changes.
Can treatment regrow hair that was lost from lichen planopilaris?
Treatment is intended to control inflammation and preserve the hair follicles that remain. It cannot regrow hair in areas where lichen planopilaris has already caused permanent scarring, which is why recognizing renewed activity promptly matters.
How is lichen planopilaris monitored after medication is reduced or stopped?
A dermatologist may review symptoms, examine the scalp, use trichoscopy to look closely at the follicles, and compare standard photographs over time. These checks can help detect subtle inflammation or spreading hair loss even when you do not feel symptoms.

Get notified when new evidence is published on Lichen planopilaris.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (6)
  1. 1

    Management of classic lichen planopilaris: The EADV task force on hair diseases position statement.

    Seyed Jafari SM, Starace M, Katoulis A, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2026; (40(8)):1306-1317 doi:10.1111/jdv.70379.

    PMID: 41848299
  2. 2

    Treatment of Lichen Planopilaris and Frontal Fibrosing Alopecia: A Retrospective, Real-Life Analysis in a Tertiary Center in Germany.

    Stege H, Haist M, Schultheis M, et al.

    Journal of clinical medicine 2024; (13(16)) doi:10.3390/jcm13164947.

    PMID: 39201087
  3. 3

    Lichen Planopilaris in Women: A Retrospective Review of 232 Women Seen at Mayo Clinic From 1992 to 2016.

    Larkin SC, Cantwell HM, Imhof RL, et al.

    Mayo Clinic proceedings 2020; (95(8)):1684-1695 doi:10.1016/j.mayocp.2020.02.028.

    PMID: 32753140
  4. 4

    Exploring Remission Dynamics and Prognostic Factors in Lichen Planopilaris: A Retrospective Cohort Study.

    Lyakhovitsky A, Zilbermintz T, Segal Z, et al.

    Dermatology (Basel, Switzerland) 2024; (240(4)):531-542 doi:10.1159/000538355.

    PMID: 38574470
  5. 5

    Treatment of lichen planopilaris: methotrexate or cyclosporine a therapy?

    Bulbul Baskan E, Yazici S

    Cutaneous and ocular toxicology 2018; (37(2)):196-199 doi:10.1080/15569527.2017.1382503.

    PMID: 28944688
  6. 6

    Lichen planopilaris and frontal fibrosing alopecia: review and update of diagnostic and therapeutic features.

    Fechine COC, Valente NYS, Romiti R

    Anais brasileiros de dermatologia 2022; (97(3)):348-357 doi:10.1016/j.abd.2021.08.008.

    PMID: 35379508

This page explains relapse and medication tapering in lichen planopilaris for informational purposes only and does not constitute medical advice. Follow your dermatologist’s or prescribing clinician’s guidance before changing treatment.